Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia

被引：0
|
作者：
Elena Ceccacci
Saverio Minucci
机构：
[1] European Institute of Oncology,Department of Experimental Oncology and Drug Development Program
[2] University of Milan,Department of Biosciences
来源：
British Journal of Cancer | 2016年 / 114卷
关键词：
leukaemia; histone deacetylases; HDACi; cancer stem cells; APL; epigenetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Histone deacetylases (HDACs) are a key component of the epigenetic machinery regulating gene expression, and behave as oncogenes in several cancer types, spurring the development of HDAC inhibitors (HDACi) as anticancer drugs. This review discusses new results regarding the role of HDACs in cancer and the effect of HDACi on tumour cells, focusing on haematological malignancies, particularly acute myeloid leukaemia. Histone deacetylases may have opposite roles at different stages of tumour progression and in different tumour cell sub-populations (cancer stem cells), highlighting the importance of investigating these aspects for further improving the clinical use of HDACi in treating cancer.
引用
收藏
页码：605 / 611
页数：6
相关论文
共 50 条
  • [41] Chromatin and cancer - the role of histone deacetylases
    不详
    AMINO ACIDS, 2005, 29 (01) : 8 - 8
  • [42] Histone deacetylases, transcriptional control, and cancer
    Cress, WD
    Seto, E
    JOURNAL OF CELLULAR PHYSIOLOGY, 2000, 184 (01) : 1 - 16
  • [43] Histone Deacetylases and their Inhibitors in Colorectal Cancer Therapy: Current Evidence and Future Considerations
    Garmpis, Nikolaos
    Damaskos, Christos
    Garmpi, Anna
    Nonni, Afroditi
    Georgakopoulou, Vasiliki E.
    Antoniou, Efstathios
    Schizas, Dimitrios
    Sarantis, Panagiotis
    Patsouras, Alexandros
    Syllaios, Athanasios
    Vallilas, Christos
    Koustas, Evangelos
    Kontzoglou, Konstantinos
    Trakas, Nikolaos
    Dimitroulis, Dimitrios
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (17) : 2979 - 2994
  • [44] Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
    Verza, Flavia Alves
    Das, Umashankar
    Fachin, Ana Lucia
    Dimmock, Jonathan R.
    Marins, Mozart
    CANCERS, 2020, 12 (06) : 1 - 28
  • [45] Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis
    Takebe, Mariko
    Oishi, Hirofumi
    Taguchi, Kumiko
    Aoki, Yuta
    Takashina, Michinori
    Tomita, Kengo
    Yokoo, Hiroki
    Takano, Yasuo
    Yamazaki, Mitsuaki
    Hattori, Yuichi
    JOURNAL OF SURGICAL RESEARCH, 2014, 187 (02) : 559 - 570
  • [46] Inhibition of histone deacetylases by dihydroxamate-containing compounds
    Bayless, Luke
    Kim, Sung-Kun
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [47] Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
    Mikkel Staberg
    Signe Regner Michaelsen
    Rikke Darling Rasmussen
    Mette Villingshøj
    Hans Skovgaard Poulsen
    Petra Hamerlik
    Cellular Oncology, 2017, 40 : 21 - 32
  • [48] Inhibition studies of histone deacetylases involving trichostatin a analogs
    Beaubien, R
    Baldwin, M
    Tischler, JL
    Zand, AR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U476 - U476
  • [49] Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
    Staberg, Mikkel
    Michaelsen, Signe Regner
    Rasmussen, Rikke Darling
    Villingshoj, Mette
    Poulsen, Hans Skovgaard
    Hamerlik, Petra
    CELLULAR ONCOLOGY, 2017, 40 (01) : 21 - 32
  • [50] Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
    Lombardi, Patrick M.
    Cole, Kathryn E.
    Dowling, Daniel P.
    Christianson, David W.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2011, 21 (06) : 735 - 743
12345